Management of Children With or Exposed to HIV

  • Authors: James A. McAuley, MD, MPH; Mariam Aziz, MD (More Info)
  • Associate Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/12/18 (What's New)

Summary

  • Incidence of opportunistic infections in children with HIV has decreased with the availability of effective ART[Gona 2006; Nesheim 2007]
  • PCP prophylaxis indicated in all infants younger than 12 months of age and children with severe immune suppression (aged 1 to younger than 6 years with a CD4+ cell count < 500 cells/mm3 or percentage < 15% or 6 years of age or older with CD4+ cell count < 200 cells/mm3 or percentage < 15%), preferably with sulfamethoxazole/trimethoprim[DHHS OI HIV Pediatric]
  • Mycobacterium avium complex prophylaxis with weekly azithromycin or clarithromycin is recommended for children based on their age and CD4+ cell count[DHHS OI HIV Pediatric]

Action required

Keywords: Pediatric/Adolescent Patients, Pediatric/Adolescent Patients , Pneumocystis jiroveci pneumonia (PCP), Tuberculosis

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.